Since the establishment of Abdulrehman Algosaibi GTC in 1944, we have had a long and rich history supporting our partners, clients and employees. Our aim as a healthcare provider is to ensure that patients get the best care possible within the Kingdom of Saudi Arabia. As the CEO of Abdulrehman Algosaibi GTC for more than two decades, I have been entrusted to carry on this legacy.

Our employees are at the centre of our success. We have talented, dedicated and passionate professionals, who work each day towards achieving our company’s vision and mission. The work we do makes a difference in the quality of life for the citizens of Saudi Arabia, and knowing this gives us purpose in providing the highest quality of services and products to the Kingdom.

Based on our reputation of delivering on our commitments, we have become the partner of choice for over 125 of the world’s largest multinational companies. Our successful track record in importing, distributing and marketing – coupled with our Kingdom-wide logistic services – makes us a clear choice as a strategic partner in Saudi Arabia. The sectors we represent for include pharmaceuticals, medical and scientific equipment, dental, laboratory and veterinary products. Through our consistent performance and achievements, Abdulrehman Algosaibi GTC is recognised as one of the top trading companies in the Kingdom, and as a result, we have the distinction of being awarded among the Top 100 Companies in Saudi Arabia.

Mohammed Ali Hammad, CEO, Abdulrehman Algosaibi GTC

The Pharmaceutical and Biological Operations Division in Abdulrehman Algosaibi GTC is a leading supplier of pharmaceutical products within the Saudi market. We have a comprehensive and diversified portfolio that is considered the gold standard for product sourcing and distribution in the market. We are always looking to find strategic collaborations with manufacturers to bring more innovative products to the market. The Pharmaceutical Division is home to some of the world’s most renowned multinational pharmaceutical companies including Pfizer, considered a strategic partner since 1984. Since then, we have built a thriving business backed by loyal clients who have come to value our joint commitment to innovation and adaptation in an ever-changing and dynamic market, all while continuing to deliver best-in-class services and products.

We share with Pfizer its successful expansion journey into the Saudi market, being the first pharmaceutical multinational company to be awarded a trading license. Abdulrehman Algosaibi GTC and Pfizer both support Saudi Vision 2030, and as part of our commitment, we have strategically aligned with the government to assure supply integrity. Millions of patients in Saudi Arabia have benefited from Pfizer’s innovative and diversified therapies and vaccines. Through our partnership with the Saudi Ministry of Health and Pfizer, we have been able to help in protecting more than five million children and adults in Saudi Arabia from serious infections of invasive and mucosal pneumococcal disease in the past years.

Customer and client care is not only close to my heart, but one of our core values. Our team is solution orientated, and we are always looking for innovative ways to support not only our partners but the industry as a whole. I make it a point to remain uniquely close to and in touch with our partners and clients in order to service their requirements. I believe that this personal connection adds enormous value and authenticity to our relationship, which is the essence of our value proposition and offer.

As I look to future, I am confident that our company is in excellent shape for further strategic ventures with new partners, all while continuing to support our current partnerships. Our team will continue to work alongside our partners, clients, customers and community members to ensure a bright future for generations to come.    

Sincerely,

Mohammed Ali Hammad

Chief Executive Officer

Khaled Harb, General Manager of the Pharma and Biological Operations, Abdulrehman Algosaibi GTC

Our strategic long-lasting partnership with Pfizer was based on a careful design and ongoing commitment to be successful. We never put ourselves on a cruise control situation but together we navigated the business context challenges away from the risk of missing obstacles in the road or failing to see upcoming turns. Our continuous commitment to review, improve, resolve issues and navigate change will always mean we have the ability to grow and deliver increasing Pfizer’s value.

Sincerely,

Khaled Harb

General Manager Pharma and Biological Operations